The Center for Clinical Epidemiology and Biostatistics (CCEB) and the Abramson Cancer Center (ACC), an NCI-designated Comprehensive Cancer Center, in collaboration with the Division of Hematology-Oncology of the Department of Medicine and the Division of Oncology of the Department of Pediatrics, all of the University of Pennsylvania (Penn) School of Medicine, propose to continue an innovative, rigorous, and successful two- to three-year training program for clinical investigators in cancer clinical epidemiology. This training program attracts cancer clinical epidemiology trainees from institutions nationwide;its graduates are placed in institutions nationwide, resulting in a program of high impact. The training program consists of required courses in clinical epidemiology, research methodology, biostatistics, and cancer clinical epidemiology;elective courses relevant to the trainees'methodologic interests;journal clubs and clinical research conferences conducted by participating faculty, the CCEB, ACC, and adult and pediatric oncology divisions;extensive independent readings;instruction in the responsible conduct of research;an apprenticeship-type experience with an experienced investigator (recommended);and the completion of an independent publishable research project in cancer clinical epidemiology. The program will: 1) train physicians to be rigorous and independent academic investigators able to use the range of approaches available in epidemiology to address research issues in cancer related to the etiology, prognosis, prevention and early detection, treatment, clinical economics, technology assessment, medical decision making, and quality of patient care;2) provide closely mentored research experiences with faculty preceptors in clinical epidemiology and cancer;and 3) strengthen the links between traditional epidemiology and cancer. Trainees will matriculate in the Master of Science in Clinical Epidemiology (MSCE) program. Strengths of the proposed program are: 1) the long history of successful research training programs in the CCEB, ACC, and adult and pediatric oncology divisions, including this training program;2) the collaborative links that have been forged among faculty with interests in clinical research in cancer;3) the comprehensive course offerings and research programs that are available to trainees;and 4) an extensive set of experienced and multidisciplinary faculty with successful training records. In addition, numerous existing large databases that can be used for research projects and training;a broad array of specialized analytic capabilities available for clinical studies employing methods of clinical epidemiology (e.g., clinical trials, case-control, cohort research, etc.);and commitment of faculty to collaborative research and training, combine to provide an ideal environment for this training program. Finally, Penn and the School of Medicine promote an academic environment in which basic and clinical research are encouraged and viewed as attractive career paths for physicians.
There is a major national shortage of qualified clinician-scientists able to conduct the rigorous clinical research needed to optimize cancer treatment and prevention. This training program addresses this shortage through the efforts of a distinguished, experienced, and committed training program faculty. Training will continue to be provided to those who desire careers as clinician-scientists focusing on cancer clinical research through a program that provides trainees with the skills needed to design and conduct epidemiologic studies that will address the most vexing population-based questions in cancer.
|DiNardo, Courtney D; Ogdie, Alexis; Hexner, Elizabeth O et al. (2013) Characteristics and outcome of acute myeloid leukemia in patients with a prior history of autoimmune disease. Leuk Lymphoma 54:1235-41|
|DiNardo, Courtney D; Propert, Kathleen J; Loren, Alison W et al. (2013) Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia. Blood 121:4917-24|
|de Blank, Peter; Zaoutis, Theoklis; Fisher, Brian et al. (2013) Trends in Clostridium difficile infection and risk factors for hospital acquisition of Clostridium difficile among children with cancer. J Pediatr 163:699-705.e1|
|Olin, Rebecca L; Kanetsky, Peter A; Ten Have, Thomas R et al. (2010) Determinants of the optimal first-line therapy for follicular lymphoma: a decision analysis. Am J Hematol 85:255-60|
|Gor, Priya P; Su, H Irene; Gray, Robert J et al. (2010) Cyclophosphamide-metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a retrospective cohort study. Breast Cancer Res 12:R26|
|Olin, R L; Vogl, D T; Porter, D L et al. (2009) Second auto-SCT is safe and effective salvage therapy for relapsed multiple myeloma. Bone Marrow Transplant 43:417-22|
|Orsey, Andrea D; Belasco, Jean B; Ellenberg, Jonas H et al. (2009) Variation in receipt of opioids by pediatric oncology patients who died in children's hospitals. Pediatr Blood Cancer 52:761-6|
|Olin, Rebecca L; Nichols, Kim E; Naghashpour, Mojdeh et al. (2008) Successful use of the anti-CD25 antibody daclizumab in an adult patient with hemophagocytic lymphohistiocytosis. Am J Hematol 83:747-9|
|Kruper, Laura L; Spitz, Francis R; Czerniecki, Brian J et al. (2006) Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma. Cancer 107:2436-45|
|Colilla, Susan; Kantoff, Philip W; Neuhausen, Susan L et al. (2006) The joint effect of smoking and AIB1 on breast cancer risk in BRCA1 mutation carriers. Carcinogenesis 27:599-605|
Showing the most recent 10 out of 17 publications